Bayer
Bayer announces major restructure, 12,000 jobs to go
November 30, 2018Medical Communications, Sales and Marketing Bayer, job cuts, monsanto, pharma
Bayer has announced a major restructure of its operations in 2019 which will see the loss of 12,000 of its …
NICE recommends Bayer’s Stivarga for advanced hepatocellular carcinoma
November 29, 2018Sales and Marketing Bayer, NICE, Stivarga, UK, pharma
The National Institute for Health and Care Excellence (NICE) has voiced its recommendation for Bayer’s Stivarga (regorafenib) for use on …
Bayer’s Jivi approved in Europe for previously treated haemophilia A
November 28, 2018Research and Development, Sales and Marketing Bayer, Jivi, haemophilia, pharma
Bayer has revealed that its recombinant Factor VIII (rFVIII) replacement therapy Jivi, also known as BAY94-9027, has received approval from …
Top Ten most popular articles on Pharmafile.com this week
October 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit
Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …
Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug
October 16, 2018Manufacturing and Production Bayer, CCG, NHS, Novartis, avastin, wet AMD
Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning …
Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO
October 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals
Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …
Bayer to cut 227 positions in California to drive efficiency in haemophilia
October 4, 2018Manufacturing and Production Bayer, haemophilia, pharma
Bayer has announced its intention to axe 227 employees at a manufacturing site in California as part of a push …
Top Ten most popular articles on Pharmafile.com this week
September 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma
Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …
Courts back NHS in fight against Novartis and Bayer
September 24, 2018Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis
The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …
Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration
August 20, 2018Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma
Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …
Bayer expands Broad Institute partnership to focus on heart failure
July 3, 2018Manufacturing and Production, Research and Development Bayer, broad institute, collaboration, heart failure, pharma
The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …
Bayer eyes R&D cuts, as Monsanto deal raises question of focus
June 1, 2018Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical
When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …
Bayer contraceptive implant public backlash brings results
April 12, 2018Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical
Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …
Bayer-Monsanto deal one step closer, after EU nod
March 22, 2018Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical
The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …
NICE recommends thyroid cancer drug trio for NHS use
February 20, 2018Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer
NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
